Different organizations have used different criteria to define prediabetes. In order to define prediabetes, the World Health Organization (WHO) use two specific parameters: Impaired Glucose Tolerance (IGT), Oral Glucose Tolerance Test (OGTT). A person who has impaired glucose tolerance or fasting glucose and at high risk of developing type 2 diabetes is said to have prediabetes. Changes in lifestyle, such as losing weight and exercising or taking metformin is considered as the first line treatments for prediabetes. Nearly 8% of the world’s population is expected to have prediabetes by 2040, and 70% of those people will eventually develop type 2 diabetes. Before fully developing diabetes, most people go through a stage of prediabetes. HbA1c or fasting plasma glucose should be used to screen for diabetes in people over 40 and other high-risk individuals. Despite its preventable nature, prediabetes often goes undiagnosed, leading to delayed interventions that can result in long-term health complications. This underscores the importance of widespread awareness, effective screening methods, and access to healthcare resources for early diagnosis and management. Moreover, emerging evidence suggests a link between prediabetes and cognitive decline, indicating that the ramifications of this condition extend beyond physical health. This short overview speaks about risk factors, diagnosis and therapy of prediabetes.
Read full abstract